Insider Buying: Reckitt Benckiser Group plc (LON:RKT) Insider Acquires 350 Shares of Stock

Reckitt Benckiser Group plc (LON:RKTGet Free Report) insider Tamara Ingram bought 350 shares of the business’s stock in a transaction on Wednesday, June 5th. The stock was purchased at an average price of GBX 4,509 ($57.77) per share, for a total transaction of £15,781.50 ($20,219.73).

Reckitt Benckiser Group Stock Up 0.6 %

Shares of RKT stock opened at GBX 4,526 ($57.99) on Friday. The firm has a fifty day moving average of GBX 4,405.51 and a 200-day moving average of GBX 5,043.23. The company has a quick ratio of 0.46, a current ratio of 0.64 and a debt-to-equity ratio of 100.80. Reckitt Benckiser Group plc has a 12-month low of GBX 4,102.64 ($52.56) and a 12-month high of GBX 6,310 ($80.85). The company has a market capitalization of £31.87 billion, a price-to-earnings ratio of 1,993.83, a P/E/G ratio of 1.64 and a beta of 0.06.

Wall Street Analyst Weigh In

Separately, HSBC reiterated a “hold” rating on shares of Reckitt Benckiser Group in a report on Thursday, April 18th.

View Our Latest Analysis on RKT

Reckitt Benckiser Group Company Profile

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Recommended Stories

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.